Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma
NCT00145145
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
OTHER
Sponsor class
Stopped
Poor Accrual
Conditions
Malignant Melanoma
Interventions
BIOLOGICAL:
MAGE-3.A1 peptide and CpG 7909
Sponsor
Ludwig Institute for Cancer Research